Showing results (1171-1180 of 1,676) with videos related to
Sort By:
Pageof 168
Journal of Chemical Theory and Computation|June 23, 2020
Performance of Coupled-Cluster Singles and Doubles on Modern Stream Processing ArchitecturesB Scott Fales, Ethan R Curtis, K Grace Johnson, et al.Rheumatology and Therapy|June 22, 2023
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE RegistryJeffrey R Curtis, Huifeng Yun, Lang Chen, et al.Chest|October 10, 2017
A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia AntibodiesCurtis G Jones, Shannon M Pechauer, Brian R Curtis, et al.Arthritis Care & Research|April 26, 2018
A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator TrialsMaarten Boers, Jasvinder A Singh, Stacey S Cofield, et al.Arthritis Care & Research|April 19, 2018
Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative StudyIris Navarro-Millán, Anne Zinski, Sally Shurbaji, et al.Blood|August 30, 2002
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIaDaniel W Bougie, Peter R Wilker, Elizabeth D Wuitschick, et al.European Journal of Human Genetics : EJHG|June 25, 2002
Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigreesFlorian Kronenberg, Hilary Coon, R Curtis Ellison, et al.Journal of Palliative Medicine|January 10, 2020
"I'd Have to Basically Be on My Deathbed": Heart Failure Patients' Perceptions of and Preferences for Palliative CareRachel A Hadler, Brett R Curtis, Dara Z Ikejiani, et al.Pharmacoepidemiology and Drug Safety|September 17, 2013
Identifying newly approved medications in Medicare claims data: a case study using tocilizumabJeffrey R Curtis, Fenglong Xie, Rui Chen, et al.Clinical Therapeutics|July 12, 2014
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claimsJeffrey R Curtis, Vernon F Schabert, David J Harrison, et al.Pageof 168